NCT04331639View on ClinicalTrials.gov

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

September 1, 2024

Study Completion Date

December 31, 2025

Conditions

Inflammatory Bowel DiseaseCrohn DiseaseUlcerative ColitisVitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

vitamin D3

Subjects will receive oral high dose interval vitamin D3, concurrently when they are receiving their biologic treatment for their inflammatory bowel disease every 4-8 weeks.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors

lead

Boston Children's Hospital

OTHER